• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FineHeart Successfully Tests Wireless TET System

    Apria Healthcare Settles Whistleblower Lawsuit

    OraSure’s OMNIgene·ORAL Device Included in COVID-19 EUA Amendment

    Remote Patient Monitoring Market Set to Surpass $645 Million by 2025

    4C Medical Technologies Completes $10 Million Over-Subscribed Convertible Note Financing
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Concise Engineering

    Unicep

    Creganna Medical, part of TE Connectivity

    K-Tube Technologies

    maxon
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    maxon

    PTI Engineered Plastics Inc.

    K-Tube Technologies

    Qosina Corp.

    Creganna Medical, part of TE Connectivity
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Keystone Heart and Venus MedTech Partner for Cerebral Embolic Protection

    Collaboration announced in wake of new published guidelines pointing to need for cerebral protection during TAVR.

    Keystone Heart and Venus MedTech Partner for Cerebral Embolic Protection
    The TriGuard Cerebral Embolic Protection Device
    Related CONTENT
    • Boston Scientific Recalls, Discontinues LOTUS Edge Aortic Valve
    • Repairing the Heart Without Opening the Body
    • NeuroMetrix Reports Substantial Expansion of International IP Assets for Quell Technology
    • FDA Approves First First Flexible Shaver for Interventional Gastroenterology
    • Data Reaffirms Value of LivaNova’s Aortic Valve Replacement Technology
    Keystone Heart Ltd. 03.14.17
    Keystone Heart Ltd., a developer of cerebral embolic protection devices for patients undergoing cardiac procedures, and Venus Medtech (Hangzhou) Inc., a Chinese transcatheter heart valve company, have forged a partnership agreement to provide Venus Medtech’s TAVR system in combination with Keystone Heart’s TriGuard Cerebral Embolic Protection Device. This agreement, covering China and key Asian markets, will allow physicians and patients in this region to benefit from TAVR while simultaneously receiving complete three vessel embolic protection for the brain.  The combination is unavailable in any other market or from any other company.

    “It is of utmost importance to us that our devices improve the quality life of the patients whom receive them,” said Eric Zi, president and CEO of Venus Medtech. “Our transcatheter heart valve systems offer patients life-saving support— and collaborating with Keystone Heart allows us the opportunity to reduce the risk of brain injury during the procedure. No other company offers this combination.”

    In February 2017, the Neurologic Academic Research Consortium (NeuroARC) published formal guidelines that establish and provide standardized consensus definitions for neurologic endpoints in cardiovascular clinical trials. Released in the Journal of American College of Cardiology and the European Heart Journal, these guidelines highlight a growing body of evidence pointing to the existence of “covert” brain injury to patients undergoing transcatheter aortic valve replacement (TAVR) and other cardiovascular procedures.

    Highlighting this issue, over the last five years, a total of 13 studies conducted in the United States and Europe have shown that a median of 80 percent of patients have new brain lesions following TAVR. In recent research in U.S. institutions, the NeuroTAVR study demonstrated that 94 percent of patients had new lesions in the brain following the TAVR procedure, 22.6 percent of patients had new neurologic impairment post TAVR, and 41 percent of patients had declining neurocognition at 30 days when compared to pre-TAVR scores in the United States. 

    “Providing brain protection for every TAVR patient will differentiate Venus Medtech and position them as a leader in structural heart therapies—underscoring its dedication to excellence and focus on patient safety,” said Chris Richardson, president and CEO of Keystone Heart. “This partnership provides us the opportunity to make an impact in the fast-growing structural heart space in an  important geographic market.”

    China is an emerging market for TAVR procedures. Venus Medtech expects its TAVR device will be the first device approved by the China Food and Drug Administration for marketing in China. Experts predict that there will be more than 10,000 procedures conducted in the first three years following approval and the market is expected to grow 30 percent to 50 percent per year in the following years.

    TAVR, which is also referred to as transcatheter aortic valve implantation (TAVI),  is a minimally invasive surgical procedure conducted to repair a damaged aortic valve. A damaged aortic valve obstructs blood flow from the heart into the aorta and onward to the rest of the body, and if left untreated, may lead to death. There will be approximately 125,000 TAVR procedures conducted this year worldwide.

    Venus Medtech (HangZhou) Inc. is a heart valve developer in China. Its transcatheter aortic valves have completed clinical trials and follow-up studies, and are pending China Food and Drug Administration clearance. Its transcatheter pulmonic valves are completing clinical trials. Both of the valves are expected to be the first transcatheter valves approved in China. They are also developing the next-generation heart valves designed for increased safety and long term durability.

    Keystone Heart's TriGuard is the only cerebral protection device designed to provide full coverage to all brain territories to minimize the risk of cerebral damage during TAVR and other cardiovascular procedures. The CE marked TriGuard device is shaped to accommodate anatomic variations of the aortic arch. Formed to withstand potential interface with the TAVR delivery system and other procedure related accessories, it uses a Nitinol frame and mesh—flexible and atraumatic, yet robust and sturdy.

    The TriGuard Cerebral Embolic Protection Device is placed through one of two femoral artery access ports typically used in TAVR, thereby eliminating the need for a third puncture site. It deploys rapidly, and self-positions through a small 9F catheter. TriGuard provides stable, atraumatic protection, with simple retrieval. 

    The TriGuard Cerebral Embolic Protection Device has been granted CE Mark approval in the European Union and is commercially available in Europe. In the United States, the device is currently available for investigational use only.

    Keystone Heart Ltd. develops and manufactures cerebral embolic protection devices to reduce the risk of stroke, neurocognitive decline and dementia caused by brain emboli associated with cardiovascular procedures. The company is focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR, atrial fibrillation ablation and other cardiovascular procedures. The TriGuard product pipeline is designed to help interventional cardiologists, electrophysiologists and cardiac surgeons to preserve brain reserve while performing these procedures.
    The company is headquartered in Israel and has U.S. operations in Tampa, Fla.
    Related Searches
    • europe
    • valve
    • ce mark
    • atrial fibrillation
    Related Knowledge Center
    • Cardiovascular
    Suggested For You
    Boston Scientific Recalls, Discontinues LOTUS Edge Aortic Valve Boston Scientific Recalls, Discontinues LOTUS Edge Aortic Valve
    Repairing the Heart Without Opening the Body Repairing the Heart Without Opening the Body
    NeuroMetrix Reports Substantial Expansion of International IP Assets for Quell Technology NeuroMetrix Reports Substantial Expansion of International IP Assets for Quell Technology
    FDA Approves First First Flexible Shaver for Interventional Gastroenterology FDA Approves First First Flexible Shaver for Interventional Gastroenterology
    Data Reaffirms Value of LivaNova’s Aortic Valve Replacement Technology Data Reaffirms Value of LivaNova’s Aortic Valve Replacement Technology
    Four Takeaways from Recent Regulatory Audit Changes Four Takeaways from Recent Regulatory Audit Changes
    International Law International Law
    Testing Device to Reduce Stroke Risk During TAVR Testing Device to Reduce Stroke Risk During TAVR
    BrainPath Non-Disruptive Cranial Access Technology Wins CE Mark BrainPath Non-Disruptive Cranial Access Technology Wins CE Mark
    GE Healthcare Launches World’s First Dedicated Cardiovascular CT System GE Healthcare Launches World’s First Dedicated Cardiovascular CT System
    MedInvent Receives CE Mark for NasoNeb II Nasal Nebulizer MedInvent Receives CE Mark for NasoNeb II Nasal Nebulizer
    FDA Clears Siemens FDA Clears Siemens' Robot-Supported ARTIS Pheno Angiography System
    Edwards Found to Infringe on Boston Scientific Patents in Germany and U.K. Edwards Found to Infringe on Boston Scientific Patents in Germany and U.K.
    Pace of Medtech M&A Activity Not Likely to Abate in 2017 Pace of Medtech M&A Activity Not Likely to Abate in 2017
    Clarius Receives CE Mark Approval for its Wirelss Ultrasound Scanners Clarius Receives CE Mark Approval for its Wirelss Ultrasound Scanners

    Related Breaking News

    • Cardiovascular
      FineHeart Successfully Tests Wireless TET System

      FineHeart Successfully Tests Wireless TET System

      A breakthrough in treating patients with severe heart failure.
      FineHeart 01.18.21

    • Cardiovascular
      U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030

      U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030

      The use of TAVR over open surgical techniques for replacing an aortic valve has exploded globally in recent years.
      GlobalData 01.15.21

    • Cardiovascular
      WhiteSwell Issued Patent for Treatment of Acute Decompensated Heart Failure

      WhiteSwell Issued Patent for Treatment of Acute Decompensated Heart Failure

      Company adds to portfolio of 40 patents for catheter-based technology that leverages the power of the body’s natural fluid removal process.
      Business Wire 01.13.21


    • Cardiovascular
      Acutus Medical Launches AcQCross Transseptal System in Europe

      Acutus Medical Launches AcQCross Transseptal System in Europe

      The product is designed to improve safety and efficiency in any procedure requiring left heart access.
      Globe Newswire 01.08.21

    • Cardiovascular | Neurological | Surgical
      FDA OKs Rapid Medical

      FDA OKs Rapid Medical's Steerable Neurovascular Guidewire

      Provides efficient access in difficult neuro and peripheral vascular procedures.
      Business Wire 01.04.21

    • Cardiovascular
      Edwards Treats First Patient in Restore Clinical Trial

      Edwards Treats First Patient in Restore Clinical Trial

      Evaluates minimally invasive device for mitral valve disease.
      Edwards Lifesciences Corp. 12.21.20


    • Cardiovascular | Diagnostics
      Genetesis

      Genetesis' CardioFlux Imaging Tech Gains Breakthrough Status

      Leverages room temperature magnetometers to noninvasively measure heart’s naturally-generated magnetic fields.
      Business Wire 12.16.20

    • Cardiovascular
      Pandemic May Hinder Growth in Peripheral Drug-Coated Balloon Market

      Pandemic May Hinder Growth in Peripheral Drug-Coated Balloon Market

      Percutaneous transluminal angioplasty balloon procedures declined by almost 30 percent in 2020.
      GlobalData 12.15.20

    • Cardiovascular | Surgical
      Foldax Earns FDA Approval for Biopolymer Mitral Heart Valve Study

      Foldax Earns FDA Approval for Biopolymer Mitral Heart Valve Study

      Valve designs intended to resist calcification, withstand stresses and strains without failure.
      Business Wire 12.14.20


    • Cardiovascular
      Innovative Health Obtains Patent for Microlumen Reprocessing Technology

      Innovative Health Obtains Patent for Microlumen Reprocessing Technology

      Paves the way for future innovation in the field by the company.
      Innovative Health Inc. 12.11.20

    • Cardiovascular | Patient Monitoring
      FDA OKs Volta Medical

      FDA OKs Volta Medical's VX1 AI AFib Mapping Software

      Assists in real-time manual annotation of 3D anatomical, electrical maps of the atria during AFib.
      PR Newswire 12.10.20

    • Cardiovascular
      Abbott Launches OCT Virtual Reality Training for Cardiologists

      Abbott Launches OCT Virtual Reality Training for Cardiologists

      VR training improved cath lab staff learning engagement by 45 percent, knowledge retention by 72 percent.
      Abbott Laboratories 12.09.20


    • Cardiovascular
      LivaNova to Sell Heart Valve Biz to Gyrus Capital for $73M

      LivaNova to Sell Heart Valve Biz to Gyrus Capital for $73M

      Enables company to sharpen its focus within primary platforms, neuromodulation and cardiovascular.
      Business Wire 12.03.20

    • Cardiovascular
      Improved Outcomes Seen in More Complete Revascularization Using Impella Heart Pumps

      Improved Outcomes Seen in More Complete Revascularization Using Impella Heart Pumps

      Impella use led to a 29 percent reduction in MACCE at 90 days.
      Business Wire 11.30.20

    • Cardiovascular
      Draper Develops Noncontact ECG Sensor

      Draper Develops Noncontact ECG Sensor

      Enables direct measurement of the heart’s three-dimensional (3D) bioelectric field.
      Draper 11.24.20


    Trending
    • Cytotron Gains Breakthrough Status To Treat Breast, Liver, And Pancreatic Cancers
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    • Top 10 Trends In The Medical Device And Equipment Industry
    Breaking News
    • FineHeart Successfully Tests Wireless TET System
    • Apria Healthcare Settles Whistleblower Lawsuit
    • OraSure’s OMNIgene·ORAL Device Included in COVID-19 EUA Amendment
    • Remote Patient Monitoring Market Set to Surpass $645 Million by 2025
    • 4C Medical Technologies Completes $10 Million Over-Subscribed Convertible Note Financing
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Cistanche Tubulosa Botanical Shown to Attenuate Locomotive Syndrome
    Maternal Dietary Intake of Fish, Omega-3s, and Omega-6s Linked to Child Neurodevelopment
    Short Term Low-Carb Diet Linked to Remission of Type 2 Diabetes
    Coatings World

    Latest Breaking News From Coatings World

    Huntsman Finalizes Acquisition of Gabriel Performance Products
    PPG Completes COLORFUL COMMUNITIES Project at School in A. Bangsaothong Samutprakarn, Thailand
    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FineHeart Successfully Tests Wireless TET System
    Apria Healthcare Settles Whistleblower Lawsuit
    OraSure’s OMNIgene·ORAL Device Included in COVID-19 EUA Amendment
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Valeo Pharma Appoints President, COO
    Metrion, LifeArc Extend Neuroscience Alliance
    Grifols Begins COVID-19 Plasma Treatment Trial
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    JLo Beauty Launches at Sephora & Amazon
    Unilever and Alibaba Group Join Forces
    Redken Unveils Acidic Bonding Concentrate Range
    Happi

    Latest Breaking News From Happi

    A Surge in Interest for Supplements & Vitamins
    Manscaped Expands Further in Europe
    Color Street Gives Back
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Super Strong Inks Survive Tough Environments
    Ontex Honored for Mask Production
    TFP Acquires PV3 Technologies
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    OrthoPediatrics Expands Agent Network in Three European Countries
    Studies Show FlareHawk Expandable Cage Delivers Favorable Fusion, Patient Outcomes
    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login